is there a link between glp-1 drugs and blood clots recent study suggests that medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous clots., The study’s lead author, Dr. Rushad Patell of Deep Vein Thrombosis (DVT) &

Therefore, having the MTHFR gene mutation can result in sluggish drainage and detox pathways

Zhang et al., Front

Hamlet Gasoyan, Ph.D., lead author of the study and a researcher with Cleveland Clinics Center for Value-Based Care Research, said: Our study shows that patients treated for obesity with semaglutide or trizepatide lost less weight on average in a regular clinical setting compared to what is observed in randomized clinical trials

That said, dosages up to 1,200 milligrams per day have been studied with no serious adverse effects reported. However, there isnt much long-term research with high doses of NMN, according to Jillian

Continuous use: For those with chronic oxidative stress or specific medical needs, maintain consistent antioxidant supplementation

Degarelix was evaluated for safety and effectiveness in three phase II clinical trials in Europe, South Africa, North America, and Japan